Middletown, DE -- (SBWIRE) -- 09/24/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Aastrom Biosciences Inc(NASDAQ:ASTM), Prana Biotechnology Limited (ADR)(NASDAQ:PRAN), Cerus Corporation(NASDAQ:CERS), LifeVantage Corp(NASDAQ:LFVN)
Aastrom Biosciences Inc(NASDAQ:ASTM) opened the session at $0.30, remained amid the day range of $0.29 - $0.30, and closed the session at $0.290. The stock showed a negative performance of -3.01% in previous trading session. The stock gained a volume of 1.27 million shares and the average volume of the stock remained 1.98 million shares. Aastrom Biosciences, Inc., a development stage company, engages in the development of patient-specific, cell products for use in the treatment of severe, chronic ischemic cardiovascular diseases. The company was founded in 1989 and is headquartered in Ann Arbor, Michigan.
Will ASTM Get Buyers Even After The Recent Rally? Find Out Here
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) traded with volume of 1.26 million shares in the prior session and the average volume of the stock remained 984,375.00 shares. The 52 week range of the stock remained $1.81 - $6.50. The stock showed a negative movement of -10.62% and closed its session at $3.45. The market capitalization of the stock remained 140.56 million. Prana Biotechnology Limited researches and develops therapeutic drugs for the treatment of neurological disorders in Australia. It primarily focuses on the Alzheimer?s, Parkinson?s, and Huntington?s diseases, as well as various cancer and age-related macular degeneration. Prana Biotechnology Limited was founded in 1997 and is based in Parkville, Australia.
Why Should Investors Buy PRAN After the Recent Fall? Just Go Here and Find Out
Cerus Corporation (NASDAQ:CERS) exchanged 1.25 million shares and the average volume remained 495,434.00 shares. The stock escalated +1.87% and closed the session at $5.99. The beta of the stock remained 2.42 and the EPS of the stock remained -0.40. The shares outstanding of the stock remained 69.74 million. Cerus Corporation, together with its subsidiary, Cerus Europe B.V., operates as a biomedical products company that focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety.
For How Long CERS will fight for Profitability? Read This Trend Analysis report
LifeVantage Corp (NASDAQ:LFVN) gained volume of 1.21 million shares, while the average volume remained 422,838.00 shares. The stock advanced +2.30% and finished the session Friday at $2.22. The EPS of the stock remained 0.06. The one month of the stock was -7.50% and three month trend remained negative -2.20%. LifeVantage Corporation identifies, researches, develops, and distributes nutraceutical dietary supplements and skin care products. It offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; and Canine Health, a companion pet supplement formulated to combat oxidative stress in dogs.
For How Long LFVN’s Gloss will Attract Investors? Find out via this report
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)